{
  "issues": [
    "Renal laboratory values (serum creatinine, eGFR, BUN, potassium) are missing, preventing assessment of contrast safety.",
    "BMI is not provided, which is needed for weight‑based contrast dose calculation.",
    "Agent 2 recommends proceeding with contrast CT pulmonary angiography without confirming renal function, which could risk contrast‑induced nephropathy.",
    "Low‑dose non‑contrast CT chest for lung cancer screening is not an appropriate primary study for acute shortness of breath and chest pain.",
    "Alternative non‑contrast imaging for pulmonary embolism (e.g., ventilation‑perfusion scan) is not mentioned despite potential renal impairment."
  ],
  "recommendations": [
    "Obtain a stat serum creatinine and BUN; calculate eGFR using the CKD‑EPI equation before any contrast administration.",
    "Record the patient’s height and weight to compute BMI for accurate contrast dosing.",
    "If eGFR is <30 mL/min/1.73 m², consider alternative PE imaging such as a ventilation‑perfusion (V/Q) scan or lower‑contrast protocols with pre‑ and post‑procedure hydration per ACR guidelines.",
    "If eGFR is ≥30 mL/min/1.73 m² but <60, use low‑osmolar, weight‑based contrast, limit volume to the minimum required, and implement intravenous isotonic fluid hydration before and after the scan.",
    "Document a renal risk assessment and obtain informed consent discussing the potential for contrast‑induced nephropathy.",
    "Reserve the low‑dose non‑contrast CT chest protocol for lung cancer screening or when the clinical question can be addressed without evaluating the pulmonary arteries; it is not indicated for the current acute presentation."
  ],
  "confidence": 0.86,
  "agent2_confidence": 0.72,
  "timestamp": "2025-09-11T13:50:40.472490Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-09-11T13:50:37.450990Z",
          "priority": "critical",
          "value": null,
          "status": "missing",
          "reason": "eGFR not available"
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-09-11T13:50:37.451025Z",
          "priority": "critical",
          "value": null,
          "status": "missing",
          "reason": "Creatinine not available"
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-09-11T13:50:37.451044Z",
          "priority": "important",
          "value": null,
          "status": "missing",
          "reason": "Missing BUN or creatinine for ratio."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-09-11T13:50:37.451059Z",
          "priority": "important",
          "value": null,
          "status": "missing",
          "reason": "Potassium not available"
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "eGFR not available",
          "Creatinine not available",
          "Missing BUN or creatinine for ratio.",
          "Potassium not available",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-09-11T13:50:37.451163Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal laboratory values (serum creatinine, eGFR, BUN, potassium) are missing, preventing assessment of contrast safety.\",\n    \"BMI is not provided, which is needed for weight‑based contrast dose calculation.\",\n    \"Agent 2 recommends proceeding with contrast CT pulmonary angiography without confirming renal function, which could risk contrast‑induced nephropathy.\",\n    \"Low‑dose non‑contrast CT chest for lung cancer screening is not an appropriate primary study for acute shortness of breath and chest pain.\",\n    \"Alternative non‑contrast imaging for pulmonary embolism (e.g., ventilation‑perfusion scan) is not mentioned despite potential renal impairment.\"\n  ],\n  \"recommendations\": [\n    \"Obtain a stat serum creatinine and BUN; calculate eGFR using the CKD‑EPI equation before any contrast administration.\",\n    \"Record the patient’s height and weight to compute BMI for accurate contrast dosing.\",\n    \"If eGFR is <30 mL/min/1.73 m², consider alternative PE imaging such as a ventilation‑perfusion (V/Q) scan or lower‑contrast protocols with pre‑ and post‑procedure hydration per ACR guidelines.\",\n    \"If eGFR is ≥30 mL/min/1.73 m² but <60, use low‑osmolar, weight‑based contrast, limit volume to the minimum required, and implement intravenous isotonic fluid hydration before and after the scan.\",\n    \"Document a renal risk assessment and obtain informed consent discussing the potential for contrast‑induced nephropathy.\",\n    \"Reserve the low‑dose non‑contrast CT chest protocol for lung cancer screening or when the clinical question can be addressed without evaluating the pulmonary arteries; it is not indicated for the current acute presentation.\"\n  ],\n  \"confidence\": 0.86\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal laboratory values (serum creatinine, eGFR, BUN, potassium) are missing, preventing assessment of contrast safety.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "BMI is not provided, which is needed for weight‑based contrast dose calculation.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2 recommends proceeding with contrast CT pulmonary angiography without confirming renal function, which could risk contrast‑induced nephropathy.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Low‑dose non‑contrast CT chest for lung cancer screening is not an appropriate primary study for acute shortness of breath and chest pain.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Alternative non‑contrast imaging for pulmonary embolism (e.g., ventilation‑perfusion scan) is not mentioned despite potential renal impairment.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain a stat serum creatinine and BUN; calculate eGFR using the CKD‑EPI equation before any contrast administration.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Record the patient’s height and weight to compute BMI for accurate contrast dosing.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "If eGFR is <30 mL/min/1.73 m², consider alternative PE imaging such as a ventilation‑perfusion (V/Q) scan or lower‑contrast protocols with pre‑ and post‑procedure hydration per ACR guidelines.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "If eGFR is ≥30 mL/min/1.73 m² but <60, use low‑osmolar, weight‑based contrast, limit volume to the minimum required, and implement intravenous isotonic fluid hydration before and after the scan.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Document a renal risk assessment and obtain informed consent discussing the potential for contrast‑induced nephropathy.",
        "type": "recommendation",
        "classification": "domain_safe",
        "rationale": "matches safe-whitelist 'obtain informed consent'"
      },
      {
        "text": "Reserve the low‑dose non‑contrast CT chest protocol for lung cancer screening or when the clinical question can be addressed without evaluating the pulmonary arteries; it is not indicated for the current acute presentation.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      }
    ],
    "counts": {
      "supported": 10,
      "inferred": 0,
      "domain_safe": 1,
      "unverified": 0,
      "contradicted": 0
    },
    "hallucination_score": 0.0,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.0
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 30045678.0,
        "age": 72.0,
        "hadm_id": 45678912.0,
        "hospital_expire_flag": 0.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "white",
        "other",
        "72",
        "0",
        "f",
        "egfr_ckd_epi",
        "shortness of breath, chest pain, history of diabetes and hypertension",
        "0.95",
        "bun_creatinine_ratio",
        "potassium_mmol_l"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal laboratory values (serum creatinine, eGFR, BUN, potassium) are missing, preventing assessment of contrast safety.",
      "BMI is not provided, which is needed for weight‑based contrast dose calculation.",
      "Agent 2 recommends proceeding with contrast CT pulmonary angiography without confirming renal function, which could risk contrast‑induced nephropathy.",
      "Low‑dose non‑contrast CT chest for lung cancer screening is not an appropriate primary study for acute shortness of breath and chest pain.",
      "Alternative non‑contrast imaging for pulmonary embolism (e.g., ventilation‑perfusion scan) is not mentioned despite potential renal impairment."
    ],
    "recommendations": [
      "Obtain a stat serum creatinine and BUN; calculate eGFR using the CKD‑EPI equation before any contrast administration.",
      "Record the patient’s height and weight to compute BMI for accurate contrast dosing.",
      "If eGFR is <30 mL/min/1.73 m², consider alternative PE imaging such as a ventilation‑perfusion (V/Q) scan or lower‑contrast protocols with pre‑ and post‑procedure hydration per ACR guidelines.",
      "If eGFR is ≥30 mL/min/1.73 m² but <60, use low‑osmolar, weight‑based contrast, limit volume to the minimum required, and implement intravenous isotonic fluid hydration before and after the scan.",
      "Document a renal risk assessment and obtain informed consent discussing the potential for contrast‑induced nephropathy.",
      "Reserve the low‑dose non‑contrast CT chest protocol for lung cancer screening or when the clinical question can be addressed without evaluating the pulmonary arteries; it is not indicated for the current acute presentation."
    ],
    "confidence": 0.86
  }
}